首页> 外国专利> METHOD FOR CHOOSING THE TACTICS OF MANAGEMENT OF PATIENTS WITH LIVER HEMANGIOMAS AT THE STAGE OF SURGICAL TREATMENT WITH INDICATIONS FOR EMBOLIZATION OF THE FETAL VESSEL

METHOD FOR CHOOSING THE TACTICS OF MANAGEMENT OF PATIENTS WITH LIVER HEMANGIOMAS AT THE STAGE OF SURGICAL TREATMENT WITH INDICATIONS FOR EMBOLIZATION OF THE FETAL VESSEL

机译:在手术治疗阶段选择肝血管瘤患者管理策略的方法,以胎儿栓塞的适应症

摘要

FIELD: medicine, lever surgery in particular.;SUBSTANCE: invention relates to medicine, namely to minimally invasive liver surgery. Ultrasound examination is performed and the size of the hemangioma is determined. If the diameter of the hemangioma of the right lobe of the liver is from 5 to 10 cm, then ultrasound is performed for the patient with contrast and the time of accumulation of contrast in the tumor tissue in the arterial phase, the time of removal from the tumor tissue in the venous and delayed phases is determined. Arteriovascular embolization is performed. The next day after embolization, a second ultrasound with contrast is performed and the stagnation of arterial blood flow is determined in comparison with the initial one. With stagnation of 70% or more, the surgical stage of treatment is considered complete. With stagnation from 30 to 70% and embolization with spiral emboli, radiofrequency thermal ablation is performed, and in other cases, open resection is performed. The method makes it possible to increase the effectiveness of treatment of patients with liver hemangiomas, to reduce the frequency of open resection interventions and the development of serious postoperative complications, to reduce the duration of hospital stay and mortality in this category of patients. ;EFFECT: method makes it possible to increase the effectiveness of treatment of patients with hepatic hemangiomas, primarily due to the use of insufficient stagnation of blood flow according to ultrasound studies with contrast performed on the next day after arteriovascular embolization compared to the initial values of one of the modern minimally invasive methods of local destruction, thus reducing the need for open resection interventions, and, accordingly, reduce the number of postoperative complications, hospital bed days, mortality in this category of patients. ;1 cl, 3 ex
机译:技术领域:医药,特别是杠杆手术;物质:本发明涉及医药,即微创肝脏手术。超声检查,执行和确定血管瘤的大小。如果肝脏的右叶的血管瘤的直径为5至10厘米,然后超声用于与对比度的患者和在肿瘤组织中的动脉阶段,除去从时间对比度累积的时间进行在静脉及延迟期肿瘤组织被确定。进行动脉血管栓塞。第二天栓塞后,进行与此相反的第二超声和动脉血流停滞在与最初的一比较来确定。随着70%以上的停滞,治疗的手术阶段被认为是完整的。与来自用螺旋栓子30至70%和栓塞停滞,射频消融被执行,并且在其他情况下,进行打开切除。该方法可以提高患者的治疗血管瘤肝脏的功效,减少开腹手术干预的频率和严重的术后并发症的发展,以减少这类患者在住院和死亡的时间。 ;有效:方法使得根据超声研究造影第二天动脉血管栓塞后相比的初始值来执行,能够提高治疗的患者的肝血管瘤的有效性,主要是由于使用了血液流动停滞不够的的局部破坏的现代微创方法之一,从而减少了开腹手术干预的必要性,并因此减少这一类的患者在术后并发症,住院床日,死亡人数。 1 CL,3离

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号